[Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000032:analysis; D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000502:physiology*; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000032:analysis* / Q000188:drug therapy; D011379:Prognosis; D011470:Prostatic Hyperplasia / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000032:analysis* / Q000188:drug therapy; D011944:Receptors, Androgen / Q000032:analysis*; D011956:Receptors, Cell Surface / Q000032:analysis; D011981:Receptors, Prolactin; D011987:Receptors, Steroid / Q000032:analysis*
D000726:Androgen Antagonists; D000728:Androgens; D011944:Receptors, Androgen; D011956:Receptors, Cell Surface; D011981:Receptors, Prolactin; D011987:Receptors, Steroid; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase
Receptores hormonales y otros procedimientos para predecir la respuesta clínica en el cáncer de próstata.